CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT05996328
Collaborator
(none)
1,400
2
2
30
700
23.4

Study Details

Study Description

Brief Summary

The purpose of this multi-center clinical trial is to study the efficacy and safety of providing nutritional support added to the study-defined standard of care which consists of standardized dietary education and a single dietary counseling session shortly after discharge, versus study-defined standard of care alone.

Condition or Disease Intervention/Treatment Phase
  • Other: Home-delivered meals and short-term dietary counseling
  • Other: Study -defined standard of care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-arm study: active intervention vs study-defined standard of careTwo-arm study: active intervention vs study-defined standard of care
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
Due to the nature of the intervention, participants, dietitians, and site coordinators can't be blinded. However, the investigators and outcome assessors will be blinded
Primary Purpose:
Supportive Care
Official Title:
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Anticipated Study Start Date :
Apr 1, 2024
Anticipated Primary Completion Date :
Apr 30, 2026
Anticipated Study Completion Date :
Sep 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

Study-defined standard of care

Other: Study -defined standard of care
study-defined standard of care consists of standardized dietary education and a single dietary counseling session shortly after discharge

Experimental: Home-delivered meals and short-term dietary counseling

Home-delivered, low-sodium, nutritionally robust meals for 6 weeks plus two additional remotely delivered dietary counseling sessions in addition to the study-defined standard of care.

Other: Home-delivered meals and short-term dietary counseling
Home-delivered, low-sodium, nutritionally robust meals for 6 weeks plus two additional remotely delivered dietary counseling sessions in addition to the study-defined standard of care.

Outcome Measures

Primary Outcome Measures

  1. Number of pairwise comparisons with wins of Clinical Benefit, evaluated a hierarchical composite of days alive out of hospital and =5-point difference in the change of health-related quality of life [within 6 weeks post-index hospital discharge]

    All patients randomized to intervention are compared to all patients randomized to placebo within strata. In each comparison with any two patients, a patient will win by achieving a superior clinical outcome which is determined by sequentially assessing the following criteria with evaluation halted when distinct advantage for either patient is shown: Days alive out of hospital at 6 weeks: shorter days is worse; tied, if same days alive out of hospital. Move to evaluation of 2 if tied. Change of The Kansas City Cardiomyopathy Questionnaire Clinical Summary (KCCQ-CS) at 6 weeks from baseline: the threshold for the difference is greater or equal to 5 for a win; tied, if difference is less than 5. The KCCQ-CS ranges from 0 to 100, where a higher score reflects a better outcome.

Secondary Outcome Measures

  1. DAOH at 6 months post-discharge [6 months post-discharge]

    This outcome was selected to determine whether home-delivered meals, augmented by enhanced dietary counseling, during a high-risk period have durable effects on readmission burden.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged 60 years

  • Veterans enrolled in a VHA facility

  • Hospitalized ( 24 hours) with new HF or worsening chronic HF

  • Dentition, swallowing function, etc. sufficient to safely consume food and liquid of standard composition and texture (i.e., no pureed food, no thickened liquids needed)

  • Able and willing to provide informed consent and perform study activities

Exclusion Criteria:
  • Food allergies or intolerances that cannot be accommodated by study diet

  • On dialysis or estimated glomerular filtration rate <30 at randomization

  • Serum potassium (non-hemolyzed) >6.0 mmol/L during index hospitalization

  • Heart transplant or active transplant listing

  • Left ventricular assist device present or anticipated <6 months

  • Malignancy or other non-cardiac condition limiting life expectancy to <12 months

  • Planned admission to a skilled nursing facility following hospital discharge, or discharge to other location/situation where Veteran does not have control over diet

  • Lack of space to store food for a week or equipment to prepare food

  • Severe cognitive impairment (SLUMS score <20, or <19 if less than high school education completed)

  • Severe food insecurity (5 or 6 points on the USDA 6-item Food Insecurity Screen)

  • Body mass index >50 kg/m2

  • Other medical, psychiatric, behavioral, or logistical condition which, in the clinical judgement of the site investigator, makes it unlikely the patient can effectively participate in or complete the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven Connecticut United States 06516-2770
2 VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor Michigan United States 48105-2303

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Study Chair: Scott L. Hummel, MD, VA Ann Arbor Healthcare System, Ann Arbor, MI

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT05996328
Other Study ID Numbers:
  • 2025
First Posted:
Aug 18, 2023
Last Update Posted:
Aug 18, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2023